We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
+24.25%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$600M
AUM Growth
+$109M
Cap. Flow
+$3.17M
Cap. Flow %
0.53%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AST
Asterias Biotherapeutics Inc. Series A
AST
+$3.17M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 63.09%
2 Consumer Staples 36.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$87.7B
$221M 36.91%
19,189,632
– –
MNK
2
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$205M 34.22%
1,619,968
– –
LCTX icon
3
Lineage Cell Therapeutics
LCTX
$263M
$88.6M 14.78%
22,095,035
– –
STAA icon
4
STAAR Surgical
STAA
$1.13B
$55.1M 9.19%
7,417,582
– –
CYNO
5
DELISTED
Cynosure, Inc. Class A
CYNO
$25.1M 4.18%
817,029
– –
AST
6
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$4.32M 0.72%
+641,025
New +$3.17M

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.91B AUM 19.99% 1-Year Est. Return
RMA
Roffman Miller Associates Philadelphia, Pennsylvania $1.91B AUM 28.29% 1-Year Est. Return
LWMT
Legacy Wealth Management (Tennessee) Memphis, Tennessee $1.91B AUM 17.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
HPC
Hill Path Capital New York $1.92B AUM 5.67% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Broadwood Capital's Q1 2015 Portfolio in Review

As of Q1 2015, Broadwood Capital held 6 positions worth $600M, up 22% from $490M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital's Q1 2015 filing shows 1 new position. Its largest new stake was Asterias Biotherapeutics Inc. Series A: 641,025 shares worth $4.32M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, down from 65% a quarter earlier, followed by Consumer Staples.

  • Broadwood Capital's largest Q1 2015 buy was Asterias Biotherapeutics Inc. Series A: 641,025 shares worth $4.32M.
  • Broadwood Capital's ten largest holdings make up 100% of its $600M portfolio in Q1 2015.
  • Broadwood Capital opened 1 new position and closed 0 in Q1 2015.
  • Broadwood Capital's portfolio value rose 22% quarter-over-quarter to $600M.

Based on Broadwood Capital's 13F filing for Q1 2015, filed 15 May 2015.